Double Blind Efficacy and Safety Study of Flexible-Dose vs Low-Dose Q8003 After Undergoing Primary Unilateral Total Knee Arthroplasty

NCT01055015 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
141
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

QRxPharma Inc.